-
Emergency-use authorization for COVID-19 self-test kit
A kit that allows individuals to collect their own nasal swabs and ship the specimens to a lab for COVID-19 testing received an emergency-use authorization from the Food and Drug Administration.
-
Biomarker for lipedema discovered
Researchers have identified a molecule that ties lipedema to other lymphatic diseases, such as lymphedema, and distinguishes it from obesity.
-
Study of COVID-19 saliva test
An at-home COVID-19 test, designed by Stanford researchers to be easy to use and provide results within 30 minutes, will be the focus of a study funded by the Stanford Medicine Catalyst Program.
-
Digital coach increases walking
A virtual adviser can help older adults become more physically active, a Stanford Medicine study reports.
-
SHC – ValleyCare strategic plan
A strategic plan for Stanford Health Care – ValleyCare emphasizes connection to the community, the enhancement of quality health care and purposeful integration with Stanford Medicine.
-
Flu vaccination in a time of COVID-19
It’s time to get a flu shot. In a Q&A, Shanthi Kappagoda, MD, clinical associate professor of infectious diseases, explains why it’s especially important to be vaccinated this year.
-
Top marks from LGBTQ rights group
The Human Rights Campaign Foundation, an advocacy organization for gender and sexual minorities, gives high marks to Stanford Health Care for its equitable treatment of patients and employees.
-
Dermatologic care during pandemic
Since elective procedures at Stanford Health Care resumed in April, clinicians and administrators in dermatology are caring for patients in the safest way possible.
-
Brain circuitry of dissociation
Stanford scientists identified brain circuitry that plays a role in the mysterious experience called dissociation, in which people can feel disconnected from their bodies and reality.
-
Possible cure for iron-overload disease
Motivated by the loss of a patient, a doctor leads a research effort to uncover the molecular mechanisms of hemochromatosis in the heart.
-
Trial tests antibody drug as COVID-19 treatment
Stanford Medicine has joined a multisite clinical trial testing antibodies designed to block the coronavirus from infecting human cells and shorten the course of the illness.
-
New medical students intent on research
More than a third of the students starting medical school at Stanford plan to conduct research. The unprecedented number reflects an effort by the school to turn out more physician-scientists.
-
New program in clinical informatics management
The School of Medicine is launching a yearlong master’s program for medical and other professionals who want to improve health care with management skills and technology.
